Taiwan
· Delayed Price · Currency is TWD Steminent Biotherapeutics Company Description
Steminent Biotherapeutics, Inc., a stem cell research and development company, develops and manufactures novel cellular therapeutics for the treatment of diseases with unmet or under-served medical needs.
The company focuses on Stemchymal portfolio of cell therapy research and development programs based on allogeneic stem cells that target neurodegenerative and other degenerative diseases.
Its product pipeline includes various pre-clinical and clinical stage therapeutic programs for the treatment of spinocerebellar ataxia (PolyQ SCA), osteoarthritis of the knee, other neurodegenerative diseases, acute liver failure, and post-CPR syndrome.
The company was founded in 2009 and is based in Taipei, Taiwan with additional offices in Shanghai, China; and San Diego, California.
| Country | Taiwan |
| Founded | 2009 |
| Industry | Biotechnology |
| Sector | Healthcare |
Contact Details
Address: No. 16 WenHu Street Taipei Taiwan | |
| Phone | 886 2 2627 9216 |
| Website | steminent.com |
Stock Details
| Ticker Symbol | 7729 |
| Exchange | Taipei Exchange |
| Reporting Currency | TWD |
| ISIN Number | TW0007729006 |
| SIC Code | 2836 |